Agios Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$34.16

+1.08 (+3.26%)

As of Jun 21, 10:07 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 12 75%

Hold 4 25%

Sell 0 0%

Price Target

Analyst Price Target -68.2% upside

Low Target $8.41

Average Target $10.87

High Target $14.57

Current Price $34.16

Current
$34.16

Target
$10.87

$8.41 $10.87 avg $14.57

Scenario Analysis

Bear Case

$8.41

-75.4%

Low target

Base Case

$10.87

-68.2%

Avg target

Bull Case

$14.57

+-57.3%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$46.00

-25.7% from high

52-Week Low

$22.24

+53.6% from low

Target vs 52W High

$10.87

-76.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%